| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, California 92037 [J. Y., V. L.], and Department of Pediatrics, University of California at San Diego, La Jolla, California 92093 [T. P., J. D. C., A. L. Y.]
The effects of three inhibitors of inosine monophosphate (IMP) dehydrogenase on a human erythroleukemic cell line, K562, were studied. Following incubation with these inhibitors, K562 cells underwent differentiation and accumulated hemoglobins. The induction of hemoglobin accumulation was dose dependent; maximum induction was observed at 100, 25, and 3 µM, respectively, for ribavirin, tiazofurin, and mycophenolic acid. The induction was associated with reduction of intracellular GTP content and was blocked by adding guanosine within 24 h after adding inducer. The effective dose for half-maximum induction by ribavirin was 3 times less than that for 50% inhibition of K562 proliferation; however, for tiazofurin and mycophenolic acid, it closely approximated the concentrations which suppressed cellular proliferation. Ribavirin was sequestered preferentially inside the K562 cells, and the induction by ribavirin had a greater than 30-fold increase in hemoglobin. Studies with isoelectric focusing, globin chain analyses, and immunochemical assays indicated that both A
and G
were detected and that the hemoglobin produced in the ribavirin-treated cells consisted of approximately 60% fetal hemoglobin and its acetylated equivalents. The adult-type
globin was found, while no ß globin chains were demonstrated. Thus, accumulation of fetal hemoglobin and production of
globin chain in ribavirin-treated cells are different from the pattern of hemoglobins induced by hemin.
1 This work was supported in part by grants from the NIH (DK 37039 and CA 40186). This is Publication 5408-BCR from the Research Institute of Scripps Clinic, La Jolla, Ca.
2 To whom requests for reprints should be addressed at Department of Basic and Clinical Research, BCR3, Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, CA 92037.
Received 6/13/88. Revised 11/ 4/88. Revised 4/17/89. Revised 7/ 7/89. Accepted 7/20/89.
This article has been cited by other articles:
![]() |
J. J. Gu, K. Gathy, L. Santiago, E. Chen, M. Huang, L. M. Graves, and B. S. Mitchell Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion Blood, June 15, 2003; 101(12): 4958 - 4965. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Barnes, R. A. Izydore, A. E. Eakin, and I. H. Hall Induction of Tmolt4 Leukemia Cell Death by 3,3-Disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: Specificity for Type II Inosine 5'-Monophosphate Dehydrogenase J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 790 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gu, J. Spychala, and B. S. Mitchell Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene. UTILIZATION OF ALTERNATIVE PROMOTERS J. Biol. Chem., February 14, 1997; 272(7): 4458 - 4466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |